Member Info for Vascular

Here is some history of the development of Oral Treatment with Foralumab and its safety record.
A few new investors may not havebe interested.

if successful, and can be administrated liberally due to it's excellent tolerability then imagine how the strain on health services worldwide could be reduced by home treatment.

https://pipelinereview.com/index.php/2020010973472/Antibodies/Tiziana-Reports-Phase-1-Clinical-Data-Demonstrating-Oral-Treatment-with-Foralumab-a-Fully-Human-Anti-CD3-Monoclonal-Antibody-is-Well-tolerated-in-Healthy-Volunteers.html

Anyone have a view on Open Orphan, as i am tempted to buy there as well. it looks on paper a no brainer but the SP hardly moves? any views would be gratefully received - especially any negatives..

I'm very Sorry to hear that Busymumof3.
I imagine if your invested in a share that is dealing with issues so close to home, then connection is far stronger than most other investors....there is always the added bonus for long term investors knowing that they are also helping bring new medical products into the world which will benefit future generations......

I have a mate into Charts, and he is good, but he invests often without even knowing what the company produces, and goes only from the charts....he specialises, usually in 2 or 3 specific chart situations....like shares consolidating on upward trend after a rise, or testing support levels etc ... and he does very well. I'm not sure i'm brave enough to just invest in a share because of its patterns on a chart...he's not interested in the company, has no emotional connection with the company he is investing in, just the price and position. He says price and volume is everything, it does not mater what the company says, what you hope for, what annalists say might happen next year, ...the price and volume at any particular time is the truth....at that time.

I think there are positives and negatives for both types of investing....and imo people do trade / invest ultimately according to their personality's..... just edged back up into £1.50s

As they say, every time you lose some money investing its payment on your trading education.....that only applies if you learn for your mistakes, which i have been trying to do these past 10 years, but its hard - because i am fundamentally impatient....that's why i cant invest for any specific share for any serious length of time ....so i have to try and catch them when they are about to turn ( that's the theory), so there's no long term commitment and as far as time goes, and it fits in with my personality type ...lol.

The SP has had a good run this last week....from about £1 to £1.60p ...60% increase very good but needs a break now, before the next leg up.

That's true Morg. The buying of a share is the easy part - knowing when to sell is / i find more difficult ....the profit is all made on the timing of the exit - so its good to have a plan so you recognise it when you see it.

No, i'm not Vince - whoever he is!

As were all into playing the odds by interesting in AIM, then the results being released any time now is a pretty sure bet. The results sound positive according to the feed back from RNS 4th January..... so RNS anytime, supported by very positive noises from the research team.... whats not to like. GL

"Tiziana Life Sciences plc ("Tiziana" or the "Company") - Tiziana announces completion of the clinical trial with nasally administered Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, for the treatment of COVID-19 patients in Brazil.......Anecdotal feedback from Foralumab-treated patients was positive and suggests that the treatment was well-tolerated....The scientific approaches underlying this clinical study could potentially be effective against SARs, MERS, and all variants of coronaviruses"

This trial is the first to evaluate nasally administered Foralumab to improve the immune system’s fight against coronaviruses
The topline data from the trial is expected to be available in January 2021."

Dr Thais Moreira, the lead scientist and coordinator of the clinical trial, stated:
“We are delighted to receive positive feedback from patients treated in the clinical trial. Among the positive results patients reported, the most common was that the treatment resulted in the rapid improvement in smell sensation, which is frequently lost in COVID-19 patients.”

Dr. Kunwar Shailubhai, CEO and CSO of Tiziana Life Sciences, commented:

“While we expect to get the topline data in January 2021, we are delighted with the positive feedback received from the treated patients."
“We believe this approach could potentially provide benefits to patients already infected with COVID-19 and its newly identified variants."

Which RNS are you expecting?

Happy with both of todays RNS's, can see fantastic growth from here.
Good to see this contract has now started also.
OEM customer that awarded $58.1m contract has commenced the installation, in multiple countries, of its medical imaging devices for the early detection of cardiovascular diseases. The rollout is expected to ramp-up from H2 2020/21

spouting the usual negatives......

I had not heard of LOOP until last night when i checked out Swazers charts...excellent chartist....Bought a load this morning....I think many like me....Swazer highlighted the imminent possibility of a price breakout ..... now i have began reading about it , i think I will be keeping a large chunk here for lot longer than i anticipated.

https://twitter.com/SwazersC/status/1348275526876753920/photo/1

cheers. ill try that.

Anyone know why i cant buy this share on IG ? Doesn't recognise it . It does on Halifax but that's not where my ISA is!

There seems to be two small articles published about KMK in January 2021. I'm not sure if the information contained in them is new, as the research has been ongoing for years - but why publish these now?

The first is : published on the 8th Jnauary 21 is called "Developing a flying radiation mapping solution - Using Kromek detectors to develop flying radiation drones"
and the second small article on the 5th January 21 is called
"Environmental radioactivity measurement in high–dose areas"

https://www.*************.net/developing-a-flying-radiation-mapping-solution/

Nice chart . Good support. lets build on this.

Its not as if we all get a jab in a few months time and then the virus goes away.....the virus will remain in circulation probably for ever and we will all require at least one jab / nasal spray / whatever each year for the remainder of our lives....just like its predecessors such as Polio, tetanus, flu ( influenza) , Hepatitis B and B, Rubella, Measles, whooping cough , mumps, chickenpox, and many many more less known.....

Lets have the news!